Chief R&D Officer
Thu, Jul 7, 2022
Jul 7
exercised or converted securities in FATE
17,158 shares @ $2.73
Increased holdings by +9.50%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).